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http://dx.doi.org/10.1016/j.gie.2017.09.010Can a multidisciplinary approach
improve the care of patients with
benign biliary strictures?To the Editor:
We read with great interest the article by Hu et al1 in
which the authors provide consensus guidelines for the
management of benign biliary strictures. They highlight
the role of endoscopic therapy, recommending ERCP as
a first-line option in cases with an accessible papilla while
acknowledging the roles of percutaneous intervention in
patients with an inaccessible papilla and surgery in cases
of failed ERCP. This suggests the importance of a multidis-
ciplinary approach to the treatment of patients with
benign biliary stenosis. However, recommendations
about multidisciplinary discussion of such cases are lack-
ing in their document.1 In different fields of medicine, it
has been shown that multidisciplinary team discussion
may result in an improvement in clinical outcome:2,3 an
approach that appears to also have the potential to
improve the care of patients with benign biliary stenosis.
As reported by Hu et al,1 experienced endoscopists can
now achieve good clinical results even in challenging
situations in which patients have variant anatomy.
Similarly, interventional radiologists are also able to322 GASTROINTESTINAL ENDOSCOPY Volume 87, No. 1 : 2018manage complex scenarios (such as patients with a
nondilatated biliary tree), providing successful results
also in cases refractory to standard treatment.4-7 Percuta-
neous insertion of biodegradable stents is an example of
such an intervention and has been reported as a success-
ful and safe treatment in multicentric studies, with the
advantage of not only providing durable results but
also reducing invasiveness because no long-lasting cathe-
ters or multiple interventions are required with this
approach.6-8
In light of this, the acknowledgement by the scientific
community of the importance of a multidisciplinary
approach in the treatment of patients with benign biliary
strictures is strongly advocated. Such an approach would
guarantee that each patient is offered the best option for
cure, tailored case by case to the specific needs of the
individual.DISCLOSURE
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http://dx.doi.org/10.1016/j.gie.2017.09.003Response:We thank Nicosia and colleagues1 for their comments
on our article “Asia-Pacific consensus guidelines for
endoscopic management of benign biliary strictures.”2 In
that article, we highlighted the importance of a
multidisciplinary approach to the management of benign
biliary strictures (BBSs), not only in the diagnosis but in
the treatment as well.2 The selection of treatment
approaches to BBSs depends on the clinical setting, the
patient’s condition and willingness, and the availability of
expertise, which mandate a multidisciplinary discussion
among different specialties aimed at providing a patient
with the appropriate treatment and the most optimal
outcome. As a result, we discussed the role of
endoscopic treatment, and of radiologic and surgical
intervention in an evidence-based approach, which indi-
cated the necessity of a multidisciplinary discussion among
endoscopists, radiologists, and surgeons.
The goal of treatment for BBSs is to obtain long-term
bile duct patency, which usually requires long-term (up
to 12 months) stent placement; repeated procedures for
stent exchange, especially when multiple biliary plastic
stents are deployed; and stent removal at the end of treat-
ment. This makes endoscopic management currently the
first-line option for most BBS patients with accessible
papillae.3,4 Percutaneous biliary interventions are generally
reserved for cases in which ERCP fails or cannot be per-
formed.5 In difficult or selected cases, such as complete
biliary obstruction or when a single-treatment approach
fails, combined treatment with endoscopic and percuta-
neous intervention (eg, rendezvous technique) with or
without some novel techniques (eg, magnetic compression
anastomosis) may be required before surgery is consid-
ered.6,7 To achieve the goal of successful combined treat-
ment, a multidisciplinary discussion is also inevitable in
clinical practice.
Biodegradable stent placement has recently been re-
ported, mostly in preliminary case studies, in patients with
BBSs through an endoscopic or a percutaneous approach.8,9
In their letter, Nicosia et al1 suggest that percutaneous
insertion of biodegradable stents is a successful and safe
treatment according to the results from multicentric
studies. However, the multicenter study referred to by
Nicosia et al1 was retrospectively designed and focused
only on the midterm outcome of percutaneous
biodegradable stent placement in the treatment of BBSs
that was refractory to standard bilioplasty.9 Although thiswww.giejournal.orgtechnique appears attractive for BBSs because it
theoretically does not require a long-lasting catheter place-
ment, stent migration (2%, 2/107 cases), stricture recurrence
(18%, 19/97 cases) with subsequent cholangitis (84.2%) and
choledocholithiasis (26.3%) were also reported in the
multicenter study,9 requiring reintervention and therefore
multiple procedures. In addition, biodegradable stents are
currently not widely available, and large-scale, well-designed
clinical trials are lacking to confirm its effectiveness,
long-term outcome, safety, and cost effectiveness in the
management of BBSs. As a result, biodegradable stent
placement currently cannot be recommended as a routine
practice either through ERCP or through percutaneous
intervention in the treatment of BBSs.DISCLOSURE
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